HDL376

CAS No. 147751-31-3

HDL376( HDL-376 | HDL 376 | SDZ HDL376 | SDZ-HDL376 | SDZHDL376 )

Catalog No. M27769 CAS No. 147751-31-3

HDL376 is a scavenger receptor BI inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 283 In Stock
5MG 319 In Stock
10MG 472 In Stock
25MG 753 In Stock
50MG 1051 In Stock
100MG 1414 In Stock
200MG 1841 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    HDL376
  • Note
    Research use only, not for human use.
  • Brief Description
    HDL376 is a scavenger receptor BI inhibitor.
  • Description
    HDL376 is a scavenger receptor BI inhibitor.(In Vivo):HDL376 was shown to raise HDL cholesterol in the rat (normal-fed 80 mg/kg/day), hamster (normal-fed 52 mg/kg/day, chow-fed 64 mg/kg/day), dog (normal-fed 35 mg/kg/day), rhesus monkey (12 mg/kg/day), and cynomolgus monkeymodels (12 mg/kg/day).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    HDL-376 | HDL 376 | SDZ HDL376 | SDZ-HDL376 | SDZHDL376
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    MCU
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    147751-31-3
  • Formula Weight
    256.79
  • Molecular Formula
    C12H17ClN2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)CNC(=S)Nc1cc(Cl)ccc1C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Giulia Di Marco, et al. A High-Throughput Screening Identifies MICU1 Targeting Compounds. Cell Rep. 2020 Feb 18;30(7):2321-2331.e6.
molnova catalog
related products
  • Galanin (1-13)-Masto...

    Galanin (1-13)-Mastoparan

  • Erbulozole

    Erbulozole (R 55104) is a potent synthetic microtubule inhibitor with anti-invasive, anti-tumor, and radiosensitizing activities that induces Wernicke's encephalopathy-like neurotoxicity.

  • Monatepil maleate

    Monatepil maleate (AJ-2615 maleate) is an orally active Ca2+-channel and α1-adrenoceptor antagonist and non-competitive heparanoyl-coenzyme A:cholesterol acyltransferase (ACAT) inhibitor with antihypertensive activity.